Star Therapeutics

Star Therapeutics develops antibody therapies for rare diseases. Its spin-outs, Electra and Vega, target immunologic, cancer, and hematologic conditions.
Domain
Healthcare
Status
Current Private Investment
Stage of Initial Investment
Series B
Initial Investment Year
2020